Hazel Staton

Hazel Staton has a BSc from The University of Sheffield in biochemistry and graduated in 2007. Upon graduation, Hazel joined Labcorp Biopharmaceutical CMC Services as a QC analyst in the molecular biology department and progressed to become a QC scientist.

Hazel is currently a lead scientist and provides scientific and regulatory leadership on cell and gene therapy projects, focusing on the molecular biology support for molecules in the preclinical and clinical stages of development as well as wider CMC analytical strategies. Hazel liaises with both internal and external industry experts to maximize Labcorp’s analytical capabilities and is part of an integrated team delivering innovative analytical solutions for clients' cell and gene therapy programs.